Aveo says FDA refuses to approve cancer drug
Aveo Oncology said Monday that the Food and Drug Administration has refused to approve its cancer drug tivozanib, saying the clinical trial data supporting the drug was not clear.
Join the discussion below, or Read more at FOX23.
#1 Jun 11, 2013
Finally the FDA is doing something in the public interest. We don't want another Vioxx without proper research
#2 Jun 11, 2013
Isn't research at the government cost?
#5 Jul 1, 2013
The kidney cancer community was very disappointed in the refusal by the FDA to approve AVEO. The response was similar to other drugs which can be helpful, but the side effects were less difficult. If you cannot tolerate the side effects of a drug, you usually quit, and then the cancer can grow again. Typically the FDA will approve a drug that does the same as an existing--if the side effects are easier, so this came as a big surprise.
Since many of the newer drugs for kidney cancer are now showing effect with other cancers, there was also hope that the same would be for AVEO. That means that other cancer sufferers will not have the benefit of another drug. Don't forget that there is usually no way to tell which patient will respond to any single drug, so it is important to have choices. The FDA did not help the cancer community with this decision.
#6 Jul 2, 2013
Did you forget to send the cash pay-off again??
Add your comments below
|Myriad Genetics Announces an Assay that Identif...||17 hr||Purplemouse2||3|
|gREEN tRees Purp haze, Afghani, SOur Diesel nOW...||Oct '16||D_Drank||1|
|Genetic hallmarks of acute lymphoblastic leukem...||Oct '16||Stephany McDowell||1|
|MALAT1 is a driver for metastasis||Oct '16||Kirkits||1|
|Yale Expert Speaks on Metastatic Breast Cancer ...||Oct '16||Stephany McDowell||1|
|Breast cancer diagnosis: When to seek a second ...||Oct '16||Javk||1|
Find what you want!
Search Oncology Forum Now
Copyright © 2016 Topix LLC